PRAISE (prospective randomized amlodipine survival evaluation) and criticism

JACC: Heart Failure

Volumn 1, Issue 4, 2013, Pages 315-317

  Pfeffer, Marc A ^a   Skali, Hicham ^a  

^a NONE

Author keywords

Amlodipine; Clinical trials; Heart failure; Nonischemic cardiomyopathy

Indexed keywords

AMLODIPINE; CAPTOPRIL; DIGOXIN; DILTIAZEM; LOSARTAN; PLACEBO;

ACUTE HEART INFARCTION; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; DRESSLER SYNDROME; DRUG CONTRAINDICATION; EDITORIAL; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MEDICAL LITERATURE; NONISCHEMIC CARDIOMYOPATHY; PEER REVIEW; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; PUBLICATION; RISK REDUCTION; SURVIVAL;

AMLODIPINE; CLINICAL TRIALS; HEART FAILURE; NONISCHEMIC CARDIOMYOPATHY;

AMLODIPINE; CALCIUM CHANNEL BLOCKERS; FEMALE; HEART FAILURE; HUMANS; MALE;

EID: 84881495498     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.05.005     Document Type: Editorial

References (15)

1. Williams J.F., Bristow M.R., Fowler M.B., et al. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation 1995, 92:2764-2784.
2. Packer M., O'Connor C.M., Ghali J.K., et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. NEngl J Med 1996, 335:1107-1114.
3. Yusuf S., Wittes J., Probstfield J., Tyroler H.A. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991, 266:93-98.
4. Wittes J. On looking at subgroups. Circulation 2009, 119:912-915.
5. Wang R., Lagakos S.W., Ware J.H., Hunter D.J., Drazen J.M. Statistics in medicine-reporting of subgroup analyses in clinical trials. NEngl J Med 2007, 357:2189-2194.
6. Packer M., Carson P., Elkayam U., et al. Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (Prospective Randomized Amlodipine Survival Evaluation 2) Study. JAm Coll Cardiol HF 2013, 1:308-314. PRAISE-2 Study Group.
7. Pitt B., Segal R., Martinez F.A., et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997, 349:747-752.
8. Pitt B., Poole-Wilson P.A., Segal R., et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 2000, 355:1582-1587.
9. Pfeffer M.A., Jarcho J.A. The charisma of subgroups and the subgroups of CHARISMA. NEngl J Med 2006, 354:1744-1746.
10. The effect of diltiazem on mortality and reinfarction after myocardial infarction. NEngl J Med 1988, 319:385-392. The Multicenter Diltiazem Postinfarction Trial Research Group.
11. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. J Am Coll Cardiol 2005, 46:e1-e82.
12. Turner E.H., Matthews A.M., Linardatos E., Tell R.A., Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. NEngl J Med 2008, 358:252-260.
13. Califf R.M. Better late than never. J Am Coll Cardiol HF 2013, 1:112-114.
14. De Angelis C., Drazen J.M., Frizelle F.A., et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Ann Intern Med 2004, 141:477-478.
15. Rising K., Bacchetti P., Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med 2008, 5:e217.